Tucotuzumab celmoleukin: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Tucotuzumab celmoleukin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
(No difference)
|
Revision as of 20:22, 27 September 2011
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Tucotuzumab celmoleukin is a humanized monoclonal antibody used to treat cancer. Tucotuzumab has a chelator, celmoleukin.
Template:Humanizedmonoclonals Template:SIB Template:WH Template:WS